Want to see KALA full AI Analyst Report?
KALA BIO (KALA) Income Statement
KALA BIO Income Statement
Last quarter (Q2 2026), KALA BIO's total revenue was $0.00. In Q2, KALA BIO's net income was $-1.58M. See KALA BIO’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 3.89M | $ 11.24M | |
| $ 0.00 | $ -259.00K | $ -303.00K | $ 1.33M | $ 7.14M | |
| $ 39.16M | $ 40.17M | $ 38.85M | $ 82.69M | $ 116.58M | |
| Depreciation and Amortization | $ 317.00K | $ 259.00K | $ 303.00K | $ 537.00K | $ 975.00K |
| $ -23.39M | $ -32.47M | $ -36.08M | $ -37.02M | $ -133.25M | |
| $ -39.16M | $ -40.43M | $ -39.15M | $ -81.36M | $ -109.43M | |
| $ 12.18M | $ 1.92M | $ -3.05M | $ 36.53M | $ -33.17M | |
| $ -26.98M | $ -38.51M | $ -42.20M | $ -44.82M | $ -142.60M | |
| $ -26.98M | $ -38.51M | $ -42.20M | $ -44.82M | $ -142.60M | |
| Per Share Metrics | |||||
| Basic EPS | $ -165.50 | $ -507.50 | $ -867.50 | $ -1474.00 | $ -108.32 |
| Diluted EPS | $ -165.50 | $ -507.50 | $ -867.50 | $ -1474.00 | $ -108.32 |
| Weighted Average Shares Outstanding | 162.97K | 75.92K | 48.64K | 30.41K | 1.32M |
| Weighted Average Shares Outstanding (Diluted) | 162.97K | 75.92K | 48.64K | 30.41K | 1.32M |
Currency in USD